Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cetus

Executive Summary

Will be granted an exclusive royalty-bearing patent license by the National Technical Information Service, Department of Commerce, to practice an invention embodied in U.S. patent "Activated Killer Monocytes: Tumoricidal Activity and Method of Monitoring Same." The objectives of the invention are to produce "a substantially pure, clinical grade, activated killer monocyte that will more effectively kill cancer cells, to assay AKM effectiveness in vitro, and to facilitate the body's immune response, Dec. 7 Federal Register notice announcing the license says....
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS014790

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel